Associated Papers
Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing.
Todesco E et al.
The Journal of Antimicrobial Chemotherapy, 2015
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.
Cooper DA et al.
Aids (london, England), 2014
Frequency and diversity of human immunodeficiency virus type 1 mutations associated with antiretroviral resistance among patients from Southern Brazil failing highly active antiretroviral therapy (HAART).
Figueiredo Saad F et al.
International Journal of Molecular Medicine, 2010
T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.
Naugler WE et al.
The Journal of Infectious Diseases, 2002
Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy.
Rousseau MN et al.
Journal of Acquired Immune Deficiency Syndromes (1999), 2001
Select a paper to view details